Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 257

1.

Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors.

Demirer T, Barkholt L, Blaise D, Pedrazzoli P, Aglietta M, Carella AM, Bay JO, Arpaci F, Rosti G, Gurman G, Niederwieser D, Bregni M; EBMT Solid Tumors Working Party.

Nat Clin Pract Oncol. 2008 May;5(5):256-67. doi: 10.1038/ncponc1104. Epub 2008 Apr 8. Review.

PMID:
18398414
2.

[Allogeneic hematopoietic stem cell transplantation for solid tumors in the United States: a review].

Cheng YC, Ueno NT.

Nihon Rinsho. 2003 Sep;61(9):1619-34. Review. Japanese.

PMID:
14515734
3.

Allogeneic stem cell transplantation for the treatment of advanced solid tumors.

Bregni M, Bernardi M, Ciceri F, Peccatori J.

Springer Semin Immunopathol. 2004 Nov;26(1-2):95-108. Epub 2004 Sep 11. Review.

PMID:
15378271
4.

Allogeneic hemopoietic stem cell transplantation in solid tumors.

Carnevale-Schianca F, Ricchiardi A, Capaldi A, Bucci AR, Grignani G, Rota-Scalabrini D, Fizzotti M, Aliberti S, Aglietta M.

Transplant Proc. 2005 Jul-Aug;37(6):2664-6. Review.

PMID:
16182778
5.

Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patients.

Bay JO, Fleury J, Choufi B, Tournilhac O, Vincent C, Bailly C, Dauplat J, Viens P, Faucher C, Blaise D.

Bone Marrow Transplant. 2002 Jul;30(2):95-102.

6.
7.

Posttransplant administration of cyclophosphamide and donor lymphocyte infusion induces potent antitumor immunity to solid tumor.

Eto M, Kamiryo Y, Takeuchi A, Harano M, Tatsugami K, Harada M, Kiyoshima K, Hamaguchi M, Teshima T, Tsuneyoshi M, Yoshikai Y, Naito S.

Clin Cancer Res. 2008 May 1;14(9):2833-40. doi: 10.1158/1078-0432.CCR-07-1742.

8.

Nonmyeloablative transplantation for solid tumors: a new frontier for allogeneic immunotherapy.

Espinoza-Delgado I, Childs RW.

Expert Rev Anticancer Ther. 2004 Oct;4(5):865-75. Review.

PMID:
15485320
9.

Allogeneic hematopoietic stem-cell transplantation: the next generation of therapy for metastatic renal cell cancer.

Arya M, Chao D, Patel HR.

Nat Clin Pract Oncol. 2004 Nov;1(1):32-8. Review.

PMID:
16264797
10.

Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8+ T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targets.

Stelljes M, Strothotte R, Pauels HG, Poremba C, Milse M, Specht C, Albring J, Bisping G, Scheffold C, Kammertoens T, Oelmann E, Silling G, Berdel WE, Kienast J.

Blood. 2004 Aug 15;104(4):1210-6. Epub 2004 Apr 15.

11.

Advances in allogeneic stem cell transplantation: directing graft-versus-leukemia at solid tumors.

Childs R, Srinivasan R.

Cancer J. 2002 Jan-Feb;8(1):2-11. Review.

PMID:
11895199
12.

[Reduced-intensity allogeneic hematopoietic stem cell transplantation (mini-transplantation) for solid tumors].

Makimoto A, Takaue Y.

Gan To Kagaku Ryoho. 2002 Jun;29(6):835-41. Review. Japanese.

PMID:
12090032
13.
14.

Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer.

Bishop MR, Fowler DH, Marchigiani D, Castro K, Kasten-Sportes C, Steinberg SM, Gea-Banacloche JC, Dean R, Chow CK, Carter C, Read EJ, Leitman S, Gress R.

J Clin Oncol. 2004 Oct 1;22(19):3886-92. Epub 2004 Aug 16.

PMID:
15314059
15.
16.
17.

Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation.

Champlin R, Khouri I, Anderlini P, Gajewski J, Kornblau S, Molldrem J, Shimoni A, Ueno N, Giralt S.

Bone Marrow Transplant. 2001 May;27 Suppl 2:S13-22. Review.

18.

Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man.

Slavin S, Or R, Prighozina T, Gurevitch O, Aker M, Panighari S, Shapira M, Nagler A.

Bone Marrow Transplant. 2000 May;25 Suppl 2:S54-7. Review.

PMID:
10933190
19.

A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors.

Conrad R, Remberger M, Cederlund K, Ringdén O, Barkholt L.

Haematologica. 2008 Feb;93(2):265-72. doi: 10.3324/haematol.11672.

20.

Allogeneic MHC gene transfer enhances antitumor activity of allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease.

Ohashi M, Kobayashi A, Hara H, Miura Y, Yoshida K, Kushida M, Ikarashi Y, Mandai M, Kitajima M, Yoshida T, Aoki K.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2208-15.

Supplemental Content

Support Center